Status of epidermal growth factor receptors family in hormone-dependent carcinomas of the breast and prostate with reference to serum lipids and lipoproteins

Indian Journal of Clinical Biochemistry

Volumn 16, Issue 1, 2001, Pages 42-51

  Jain, D ^a   Ray, A ^a   Bahadur, A K ^a   Chaturvodi, K U ^a   Sood, R ^b   Sharma, S ^a   Naik, S L D ^a   Sharma, B K ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

^b DR RAM MANOHAR LOHIA HOSPITAL   (India)

Author keywords

Breast cancer and prostate cancer; C erbb 2; Egf r; Lipids

Indexed keywords

EID: 0010718258     PISSN: 09701915     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02867567     Document Type: Article

References (33)

1. DuPorrt, W.D. and Page, D.L. (1985) Risk factors for breast cancer in women with proliferative breast disease. New Engl. J. Med. 312,146-151.
2. Bernstein, L. and Ross, R.K. (1993) Endogenous hormones and breast cancer risk. Epidemiol. Rev. 15, 48-65.
3. Hulka, B.S. and Stark, A.T. (1995) Breast cancer: cause and prevention. Lancet 346,883-887.
4. Persky, V.W., Chatterton, R.T., Van Horn, L.V., Grant, M.D., Langenberg, P. and Marvin, J. (1992) Hormone levels in vegetarian and nonvegetarian teenage girls: potential implications for breast cancer risk. Cancer Res. 52,578-583.
5. Knapp, M.L., Al-Sheibani, S. and Riches, P.G. (1991) Alterations of serum lipids in breast cancer effects of disease activity, treatment and hormonal factors. Clin. Chem. 37,2093-2101.
6. Boyd, N.F., Connelly, P., Lynch, H., Knaus, M., Michal, S., Fili, M., Martin, L.J., Lockwood, G. and Tritchler, D. (1995) Plasma lipids, lipoproteins, and familial breast cancer. Cancer Epidemiol. Biomarkers Prev. 4,117-122.
7. Bahadur, A.K., Yadav, R., Ray, A., Pasha, S.T., Sharma, S. and Sharma, B.K (1998) Alteration in serum lipids and host cell mediated immune response in patients of carcinoma breast before, during and after treatment. J. Basic Appl. Biomed. 6,19-24.
8. Fishman, J., Osborne, M.P. and Telang, NT. (1995) The role of estrogen in mammary carcinogenesis. Ann. N.Y. Acad. Sci. 768, 91-100.
9. De Bortoli, M., Maggiora, P., Capello, D., Antoniotti, S., Saviozzi, S., Sapei, M.L and Dati, C. (1996) Hormonal control of growth factor receptor expression. Ann. N.Y. Acad. Sci. 784,336-348.
10. Sharma, B.K., Ray, A., Kaur, S. and Gupta, S. (1999) Immunohistochemical co-expression of c-erbB-2/ Neu oncoprotein, altered tumour suppressor (p53) protein, EGF-R and EMA in histological subtypes of infiltrating duct carcinoma of the breast. Indian J. Exp. Biol. 37,223-227.
11. Fox, S.B., Persad, R.A., Coleman, N., Day, C.A., Silcocks, P.B. and Collins, C.C. (1994) Prognostic value of c-erbB-2 and epidermal growth factor receptor in stage A1 (T1 a) protatic adenocarcinoma. Br. J. Urol. 74,214-220.
12. Kukuho, M., Yoshiki, T, Hamagucha, A., Okada, Y, Tomoyoshi, T. and Higuchi, K. (1993) Immunohistochemical study of c-erbB-2 proto-oncogene product in prostate cancer. Jpn. J. Urol. 84, 1872-1878.
13. Ries, LAG., Hankey, B.D. and Edwards, B.K. (1990) Cancer statistics review 1973-87. N.I.H. Publ. 90,2789.
14. Le Marchand, L, Kolonel, LN. and Wilkens, L.R. (1994) Animal fat consumption and prostate cancer, a prospective study in Hawaii. Epidemiol. 5,276-282.
15. Ratnakar, N.,Sharma, B.K., Chaturvedi, K.U., Kaur, S., Naik, S.L.D. and Ray, A. (1998) Immunohistochemical expression of c-erbB-2 oncoprotein and EGF-R in pre- and postmenopausal breast cancer. A.P.M.I.S. 106,1075-1080.
16. Allan, C.C, Poon, L.S., Chan, C.G.S., Richmond, W. and Fu, PC (1974) Enzymatic determination of total serum cholesterol. Clin. Chem. 20,470-475.
17. Wahlefield, A.W. (1974) Triglycerides: determination after enzymatic hydrolysis. In, Methods of enzymatic analysis, Vol. II (Ed. Bergmeyer H.). Academic Press, New York, p.1831.
18. Lopes-Wella, M.F., Stone, P., Ellis, S.and Colwell, J.A. (1977) Cholesterol determinations in high-density lipoproteins separated by three different methods. Clin. Chem. 23, 882-884.
19. Friedewald, W.T., Levy, R.I. and Fredrickson, D.S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative urtracentrifuge. Clin. Chem. 18,499-502.
20. Peles, E. and Yarden, Y. (1993) Neu and its ligands: from an oncogene to neural factors. Bio. Essays 15, 815-824.
21. Lipponen, H.J., Aaltomaa, S., Syrjanen, S. and Syrjanen, K. (1993) c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer. Anticancer Res. 13,1147-1152.
22. loachim, E., Kamina, S., Athanassiadou, S. and Agnahtis, N.J. (1996) The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer. Anticancer Res. 16, 3141-3147.
23. Koutselini, H., Markopoulos, C, Lambropoulou, S., Gogas, H., Kandaraki, C. and Gogas, J. (1995) Relationship of epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and vimentin expression and various prognostic factors in breast cancer patients. Cytopathol. 6,14-21.
24. Wiltschke, C, Kindas-Muegge, J., Steininger, A., Reiner, A., Reiner, G. and Preis, P.N. (1994) Coexpression of HER-2/neu and p53 is associated with a shorter disease-free survival in node-positive breast cancer patients. J. Cancer Res. Clin. Oncol. 120, 737-742.
25. Rudas, M., Neumayer, R., Gnant, M.F., Mittelbock, M., Jakesz, R. and Reiner, A. (1997) p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast. Eur. J. Cancer 33,39-44.
26. Hiatt, A., Friedman, G.D., Bawol, R.D. and Ury, H.K. (1982) Breast cancer and serum cholesterol. J. Natl. Cancer Inst. 68,885-889.
27. Agurs-Collins, T, Kim, K.S., Dunston, G.M. and Adams, C.LL (1998) Plasma lipid alterations in African- American women with breast cancers. J. Cancer Res. Clin. Oncol. 124,186-190.
28. Qi, X.Y., Zhang, A.Y., Wu, G.L and Pang, W.Z. (1994) The association between breast cancer and diet and other factors. Asia Pacific J. Public Health 7,98-104.
29. Goodwin P.J., Boyd, N.F., Hanna, W., Hartwick, W., Murray, D., Qizilbash, A., Redwood, S., Hood, N., Delgiudice, M.E., Sidlofsky, S., McCready, D., Wilkinson, R., Mahoney, L, Connelly, P. and Page, D.L. (1997) Elevated levels of plasma triglycerides are associated with histologically defined premenopausal breast cancer risk. Nutr. Cancer 27,284-292.
30. Takatani, O., Okumoto, T. and Kosano, H. (1991) Genesis of breast cancer in Japanese: a possible relationship between sex hormone binding globulin (SHBG) and serum lipid components. Breast Cancer Res. Treat. 18 (Suppl 1), S 27-29.
31. Hoyer, A.P. and Engholm, G. (1992) Serum lipids and breast cancer risk: a cohort study of 5207 Danish women. Cancer Causes Control 3,403-408.
32. Maygarden, S., Strom, S, and Ware, J. (1992) Localization of EGFR by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia and benign hyperplasia. Arch. Pathol. Lab. Med. 116,269-273.
33. Ibrahim, G., Kerri, B., Mac Donald, J., Ibrahim, S., Kinney, R., Humphrey, P. and Robertson, C. (1993) Different immunoreactivity of EGFR in benign, dysplastic and malignant prostate tissue. J. Urol. 149, 170-173